Laurelton Heart Specialists is a clinical research site located in Rosedale, New York, United States 11422.
Crixeo Clinical Trials Trust Score: 70/100 (FAIR). This profile has not yet been claimed by the site owner.
Laurelton Heart Specialists has participated in 4 clinical trials with 3 currently active.
Therapeutic areas: Amyloid Cardiomyopathy, Transthyretin-Related, Heart Failure, Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR CM).
Sponsors: Eidos Therapeutics, a BridgeBio company, Bayer, Ionis Pharmaceuticals, Inc..
Trust Score: 70/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Laurelton Heart Specialists has a Crixeo Trust Score of 70/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Laurelton Heart Specialists has 4 clinical trials on record, with 3 currently active. Their work covers Amyloid Cardiomyopathy, Transthyretin-Related, Heart Failure, Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR CM).
Laurelton Heart Specialists has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.